What is a proven benefit of combined ARNI (sacubitril/valsartan) therapy compared to angiotensin receptor blocker (ARB) alone in patients with heart failure with reduced ejection fraction (HFrEF)?

Question

Accepted Answer

Improved survival and reduced risk of cardiovascular death

Answer

Worsened quality of life

Answer

No difference in outcomes

Answer

Increased risk of hospitalization

Crowdly

What is a proven benefit of combined ARNI (sacubitril/valsartan) therapy compare...

Want instant access to all verified answers on learning.monash.edu?